Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GLGC Gene Logic -- Ignore unavailable to you. Want to Upgrade?

To: Steve Push who wrote (77)	9/9/1999 10:27:00 PM
From: Mike McFarland	Respond to of 360

The chip is still in development. We have not done any screening yet. That is not the answer I wanted to hear, but I sure do appreciate your posts. You can be sure I keep a close eye on Gene Logic, and will for a long time to come. Good luck to all investors-- and nice to see the stock moving up of late!

To: Steve Push who wrote (77)	9/13/1999 1:18:00 PM
From: Greg Jung	Read Replies (1) \| Respond to of 360

Steve, I was under the impression that the chip was to be purchased and that GeneLogic's task was to produce instrumentation and processing software around it. (I should be reading white papers, etc. on glgc site but my computer, sans mouse, is limited to tty communications (lynx for a web browser). What relation does the glgc chip have to the Affimetrix chip, and does today's patent ruling regarding Affimetrix and Incyte have impact on GLGC prospects. P.S. This is really an open question to anybody with an educated guess of the ramifications - I'm sure Steve might be inhibited to post his complete thought on the topic. Greg